Abstract: It is reported that 6% of children and 3% of adults have food allergies, with studies suggesting increased prevalence worldwide over the last few decades. Despite this, our diagnostic capabilities and techniques for managing patients with food allergies remain limited. We have conducted a systematic review of literature published within the last 5 years on the diagnosis and management of food allergies. While the gold standard for diagnosis remains the double-blind, placebo-controlled food challenge, this assessment is resource intensive and impractical in most clinical situations. In an effort to reduce the need for the double-blind, placebo-controlled food challenge, several risk-stratifying tests are employed, namely skin prick testing, measurement of serum-specific immunoglobulin E levels, component testing, and open food challenges. Management of food allergies typically involves allergen avoidance and carrying an epinephrine autoinjector. Clinical research trials of oral immunotherapy for some foods, including peanut, milk, egg, and peach, are under way. While oral immunotherapy is promising, its readiness for clinical application is controversial. In this review, we assess the latest studies published on the above diagnostic and management modalities, as well as novel strategies in the diagnosis and management of food allergy.
Introduction
European studies estimate the lifetime prevalence of food allergy is 17.3% and the point prevalence 6%. 1 Recent studies suggest an increased prevalence worldwide over the last few decades of food allergy and food-induced anaphylaxis. 2, 3 Despite the increasing prevalence of food allergy, our diagnostic and management strategies have remained relatively unchanged over time. The double-blind, placebo-controlled food challenge (DBPCFC) is considered the gold standard for diagnosis of food allergies, but is rarely employed by physicians outside of an academic context. It is estimated that DBPCFCs have a false negative rate ranging from 2%-5% and a false positive rate near 5.4%-12.9%. 4 The open food challenge (OFC) is a more viable option for most clinicians, though it is not without its own pitfalls.
Most clinicians rely on skin prick testing (SPT) and serum-specific immunoglobulin E (sIgE) testing to establish the diagnosis of food allergy. SPT is readily performed in the clinical setting, and a near infinite number of foods can be evaluated, although extracts are not yet standardized. It is typically the first test used in the evaluation of food allergy. Measurement of sIgE for a wide variety of foods is available in most centers. These tests both evaluate the presence of IgE, which determines sensitization but does not necessarily correlate with clinical reactivity. In an effort to improve diagnostic accuracy, component testing allows the allergist to examine IgE levels against a particular protein of the culprit food. Examining sensitization profiles to specific food allergen components aims to distinguish between sensitized and truly reactive patients. 5 Some proposed novel diagnostic tests are in development, but are not yet ready for clinical application.
Management of food allergy relies primarily on allergen avoidance, with prompt emergency care for accidental exposure. Food allergen avoidance is not always effective, as allergens such as milk and egg may be hidden in foods. An estimated 10%-20% of individuals with a diagnosis of anaphylaxis experience recurrent reactions. 3, 6, 7 Despite clear guidelines advising prompt use of an epinephrine autoinjector (EAI) in anaphylaxis, many patients and families do not use an EAI, possibly due to inadequate knowledge and anxiety. 8, 9 Moreover, the diagnosis of food allergy and the need to carry an EAI are associated with negative effects on quality of life for patients and families alike. 10 A recent review found that there were no robust studies examining the effectiveness of injectable epinephrine, antihistamines, systemic glucocorticosteroids, or methylxanthines in the management of anaphylaxis. 11 As prompt use of an EAI is the most important step in the acute management of anaphylaxis, we have focused on this treatment modality. Depending on the allergen, many individuals will have lifelong food allergies. Hence, it would be advantageous to have a treatment strategy that allows for food reintroduction and obviates the need to carry an EAI. As such, recent developments in immunotherapy for foods are a very exciting prospect. Incorporating baked milk and egg in the diet may be viewed as a form of immunotherapy for these allergens, while there are other protocols under investigation to desensitize and potentially induce tolerance through gradual introduction of the raw allergen. Other allergens under investigation as candidates for immunotherapy include peanut and peach. In this systematic review, we aim to assess existing and new diagnostic modalities and management options for food allergy. In particular, we will focus on literature published in the last 5 years.
Methods
We searched the PubMed database for scientific literature published between January 13, 2009 and January 13, 2014 using the following search criteria: "food allergy" AND "management" OR "diagnosis". We used the following filters in our search: clinical trial, abstract available, and studies done on humans in any language. Of the available articles, we selected those that were relevant to this review based on the abstract. A team of six readers then further reviewed these articles. The articles have been summarized in regard to food allergy diagnosis and management in Tables 1 and 2 , respectively. Upon initial search of PubMed using the above terms, 12,139 titles appeared. After applying the filters as described, 217 titles remained. Once abstracts had been reviewed, 100 articles were warranted for inclusion in the study (Figure 1 ).
Diagnosis SPT
SPT is the primary diagnostic modality employed by most allergists. It is relatively inexpensive, can be done in the office, results are available immediately, and almost any food can be tested in this manner. Typically, an extract or fresh food is placed on the volar aspect of the forearm and the skin is pricked with an instrument. Fresh food testing can also be accomplished using the "prick-to-prick" method, where the testing device first pricks the food to be tested and is then used to prick the patient. A positive test will result in wheal formation and erythema, indicating sensitization to the allergen tested. Two studies have examined the use of end-point prick testing, or using dilutions of extract or fresh food in SPT, in predicting the outcome of the OFC. In a cohort of patients known to be milk allergic, Bellini et al 12 reported that SPT with a wheal diameter greater than 4.5 mm with a 1/10,000 dilution of fresh milk was the best test for discriminating between milk-tolerant and milk-reactive subjects. They proposed using diluted milk after SPT with milk extract to help decide who should proceed to the OFC, noting that those with a positive SPT to the 1/10,000 dilution should avoid the challenge. However, their results reveal that 50% of children with a negative SPT response to diluted milk will have a positive challenge. Tripodi et al 13 conducted a similar study using egg extract; however, their results may not be reproducible as extracts were not standardized and may have contained different levels of allergen. Johannsen et al 14 evaluated SPT and sIgE to peanut as predictors of OFC outcomes in sensitized preschoolers, demonstrating that 50% of sensitized children could safely ingest peanut. Further, with a combined SPT wheal diameter of ,7 mm and sIgE ,2 kUA/L for peanut, there is a 5% chance they will react to an OFC. It is reported that a SPT wheal diameter of 8 mm as the threshold for sesame. 15 Other researchers suggest a SPT wheal diameters of 8 mm and 7 mm for milk and egg thresholds, respectively. 16 Journal of Asthma and Allergy 2014:7 submit your manuscript | www.dovepress.com
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Optimal diagnosis and management of food allergies Higher maternal vitamin C intake showed a trend toward a reduced association with wheeze, although it was not statistically significant (P=0.06). increased maternal copper intake was associated with reduced risk of wheeze and eczema, but not food allergy.
Maternal antioxidant intake may influence the development of allergic disease in children.
Particularly, increased dietary copper may reduce wheeze and eczema at 1 year. There was no significant effect on food allergy.
Prevention in pregnancy RCT Palmer et al, 2012 52
No significant difference at age 1 year between children of mothers who were supplemented with polyunsaturated fatty acids during pregnancy and controls.
Polyunsaturated fatty acid supplementation during pregnancy does not reduce the risk of allergic disease in childhood.
Prevention in pregnancy
Peanut, tree nuts, sesame
Crosssectional Hsu et al, 2013 47 Maternal consumption of tree nut and sesame seed during the first two trimesters was associated with a 60% higher risk of having a child sensitized to tree nut, peanut, or sesame seed.
Children with asthma and environmental allergies had increased risk of sensitization.
Maternal consumption of tree nut and sesame seed leads to greater risk of having a child who is sensitized to tree nut, peanut, or sesame seed. This study did not evaluate allergy to these foods. it is unclear whether the children in the study were avoiding milk for ige-mediated allergy or intolerance. The participants in the study were receiving special infant formula reimbursement, so this may partially account for the high rate of adherence.
Preventionallergen avoidance
Milk (cow versus camel)
Prospective cohort ehlayel et al, 2011 68 80% of cow's milk-allergic children had a negative SPT response to camel milk and could safely ingest it. Children with a positive SPT response to camel milk were not challenged.
Patients in this study were not challenged to cow's milk to confirm allergy; it is possible they acquired tolerance. Camel milk could be a safe alternative to cow's milk, but this may not be practical depending on cultural influences.
Crosssectional
The percentage of people able to correctly identify more than 50% of the terms associated with a given allergen were: 4.8% of the general population, 2.9% of parents of food-allergic children, and 39.5% of health care professionals without a history of food allergy. Females, those with higher education, and those with a history of food allergy scored more highly.
Consumer confusion regarding labeling for food allergies is prevalent. Labeling must state exact terms for each allergen, and "may contain" statements should be limited to avoid misleading labels. 
74
A survey of Mississippi, USA public school nurses found that 97% of schools had at least one food-allergic student. 30% of schools had food allergy action plans. Action plans were more likely to exist when the nurse had received information from a physician.
Most schools have food-allergic students, but relatively few have action plans for these students.
Preventionallergen avoidance
Crosssectional
Ben-Shoshan et al,
72
Precautionary statement "not suitable" was most effective in deterring purchase of a product. individuals directly affected by food allergy were more likely to avoid products with "may contain", "may be processed on the same equipment as products containing", and "not suitable for" on the label than indirectly affected subjects. Households reporting a moderate/severe allergy were more likely to avoid. Identified four regions of Ara h 2 that induced T-cell proliferation in peanut-allergic children. These could potentially be used for a peptide-based vaccine for food allergy.
Used a novel approach to treatment of food allergy, but requires further study before it is ready for clinical application.
OiT Milk RCT Pajno et al, 2013
94
Children desensitized with OiT were randomized to one of two feeding regimens: daily or twice weekly. There was no difference in adverse reactions among the two groups.
Once desensitization is achieved, a twice-weekly maintenance regimen is as effective as daily maintenance.
OiT Milk Prospective cohort Nadeau et al, 2011
95
Pilot study in eleven milk-allergic children, using omalizumab to perform rapid oral desensitization. 9/10 achieved target dose of 1 g during rush desensitization. Over 7-11 weeks, 9/10 reached 2 g target.
Rush milk desensitization with omalizumab was generally successful and well tolerated. All children had adverse events, but most were mild and did not require treatment. There was one event requiring epinephrine.
Journal of Asthma and sige and component testing Measurement of IgE levels to a specific antigen is another commonly employed method in the diagnosis of food allergies. Like SPT, it assesses sensitization rather than clinical food allergy. 17 Component testing strives to delineate sensitized patients from those who will react to a given food. Peanut is one of the more extensively investigated foods in this regard. In evaluating peanut-sIgE, van Nieuwaal et al 18 found higher cutoffs for predicting OFC failure compared to previous studies. Ninety percent of participants failed the peanut challenge at an sIgE of 24.8 kUA/L, and 95% at 43.8 kUA/L. The authors attributed these findings to their study population, many of whom were diagnosed with peanut allergy without undergoing DBPCFC. In distinguishing peanut sensitization from reactivity, elevated levels of Ara h 2 tend to be associated with a reactive phenotype, 19, 20 whereas 89.5% of children with elevated Ara h 8 can safely ingest peanut. 21 In comparing peanut-sIgE, Ara h 2, and OFC results, sIgE was the most sensitive test 0.93 (93%), while Ara h 2 was the most specific and had the best positive predictive value. 19 Researchers have shown similar results in peanut-allergic Asian children. 22 In an effort to develop a more accurate test, Lin et al examined specific sequences of the peanut components and found that using a combination of four peptides Ara h 1, 2, and 3 had 90% sensitivity and 95% specificity. 23 The biomarkers generally used to monitor the effect of immunotherapy are sIgE and SPT wheal size. Kulis et al 24 examined the effect of peanut sublingual immunotherapy (SLIT) on salivary immunoglobulin A levels and found a transient elevation in the treatment group, but, by 1 year, there was no significant difference between the two groups.
Most children with egg allergy will outgrow it. Montesinos et al examined the relationships between sIgE directed towards egg white, ovalbumin, and ovomucoid, and demonstrated that these biomarkers were lower in subjects who outgrew their egg allergy. 25 Another recent finding in egg allergy is that many egg-allergic children are able to tolerate baked egg. sIgE to egg white, ovalbumin, and ovomucoid tends to be lower in children who are tolerant to baked egg. 26, 27 Further studies have examined the role of diagnostic testing in sesame, wheat, and soy allergy. For sesame, sIgE .7 kUA/L or an SPT wheal size .6 mm were both .90% specific in predicting the results of an OFC. 28 In a Japanese cohort, the median sIgE level in allergic children was 4.31 kUA/L for wheat and 3.89 kUA/L for soybean. hypersensitivity, and, as such, some health care practitioners measure food-specific IgG levels. However, in a cohort of 5,394 Chinese adults, there was no relationship between food-specific IgG levels and allergic symptoms. 30 Given that increased IgG levels to food allergens may indicate tolerance rather than allergy, this test is not used by allergists in their evaluation. 31 
Food challenges
Food challenges involve feeding the patient incremental doses of a suspected food and observing them for clinical reaction. Ideally, this is done in a double-blind, placebocontrolled manner. However, it is more practical to administer an OFC that is neither blinded nor placebo controlled. Food challenges may be performed to confirm the diagnosis of allergy or to monitor for resolution, and are often necessary due to the poor sensitivity and specificity of SPT and sIgE testing. Fleischer et al found that most children diagnosed with food allergy on the basis of immunoassays were able to reintroduce the suspected food into their diet following challenge. 32 Food challenges are also useful in establishing the diagnosis of non-IgE-mediated processes that cannot be detected by SPT or sIgE testing. 33 When performed in an appropriate setting, OFCs are an extremely safe procedure. In an evaluation of 701 OFCs performed in 521 patients, 18.8% elicited a reaction. Only 1.7% of those who reacted required treatment with epinephrine. 34 Calvani et al reported similar results: among 544 OFCs, 48.3% of patients reacted, although 65.7% had mild reactions; only 2.7% required treatment with epinephrine. 35 OFCs have been demonstrated to be a highly reproducible and valid strategy for establishing the diagnosis of food allergy. A recent study exemplified this, with 100% correlation between a positive DBPCFC and a positive singleblind OFC among patients with peanut allergy. 36 OFCs have been established as a safe and effective way to diagnose milk allergy. 37 An OFC for milk is important for several reasons. Many children will become milk tolerant with time. In fact, between 58.7% and 66% of children with suspected milk allergy will be tolerant to an OFC. 37, 38 Similar to those with an egg allergy, most milk-allergic children can tolerate baked milk. Bartnikas et al reported that 83% of the milk-allergic children they challenged were able to tolerate baked milk in their diet. In particular, they found that no child with an SPT wheal diameter ,7 mm failed the baked milk challenge, and that 90% of those with a wheal diameter under 12 mm passed the baked milk challenge. 39 Elimination diets are detrimental to health as they can be associated with nutritional deficiencies and increased anxiety among patients and families. Liberalizing the diet to include safe foods that are tolerated by the patient is essential in improving quality of life. 40 OFCs are associated with a transient increase in parental anxiety, but, in the long-term, parents and patients report improved quality of life. 41, 42 There are several methods by which OFC may be conducted, with many clinicians using individualized protocols. These protocols can vary in terms of timing, dosing, the agent used, and the definition of a positive or negative challenge. In an egg OFC, Escudero et al challenged patients to both dried egg white and raw egg white. They found that 25% of the patients reacted to both, and 75% of the patients reacted to neither, indicating that dried egg white can be used to evaluate raw egg. 43 Dried egg white offers several advantages over raw egg white, including storage capacity and palatability. Similarly, Winberg et al sought to validate recipes for use in DBPCFCs to egg, milk, cod, soy, and wheat. Using the same liquid test vehicle for each allergen, they found that children were unable to differentiate test from control doses. 44 This provides clinicians with validated recipes that are easy to prepare and effective in concealing antigen.
OFCs and blind food challenges to evaluate immediate IgE-mediated food allergy are typically started with 0.1% to 1% of the total challenge food. If known, the initial OFC dose should be lower than the expected threshold dose. According to one approach, the total amount that should be administered during a gradually escalating OFC equals 8-10 g of a dry food, 16-20 g of meat or fish, and 100 mL of wet food (eg, apple sauce). The recommended dosing interval is 15 minutes. 45 
Management Primary prevention
There are many theories regarding the origins of allergy. While we do not fully understand the etiology of allergic disease, much research has focused on how it may be prevented.
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In a cohort of infants with likely milk or egg allergy, Sicherer et al found that maternal peanut consumption during pregnancy, as well as sIgE to milk and peanut, were linked to an increased risk of having peanut-sIgE .5 kUA/L. 46 Similar findings have been reported for tree nut and sesame seeds. 47 It is important to note that these studies evaluated sensitization rather than reactivity. Mothers of peanut-allergic children reported higher consumption of peanuts during pregnancy and breastfeeding compared to mothers of non-allergic subjects. 48 However, the retrospective design of the study makes recall bias a likely explanation for this finding. In two recent cohort studies assessing clinical peanut allergy, it was reported that higher maternal peanut intake during pregnancy was associated with a reduced risk of peanut-allergic reaction in offspring. 49, 50 Other studies have assessed the influence of maternal antioxidants consumption and polyunsaturated fatty acid supplementation during pregnancy on allergic disease in children. West et al reported that increased dietary levels of copper during pregnancy were associated with lower rates of wheeze and eczema, but had no effect on food allergy in offspring. 51 There was no association between polyunsaturated fatty acid supplementation during pregnancy and prevention of allergic disease in offspring. 52 Beyond pregnancy, several studies have assessed interventions in infancy that may prevent the development of food allergy. Three studies have assessed the role of probiotic supplementation during infancy on allergic disease in childhood but failed to establish an association. [53] [54] [55] Similarly, no association was found between fish oil supplementation in infancy and allergic disease. 56 Other studies have examined how the timing of food introduction influences acquisition of tolerance. In a case-control study, Grimshaw et al reported that infants with food allergy at 2 years of age tended to have been introduced to solids at less than 16 weeks and were less likely to have received breast milk when cow's milk was introduced. 57 Other studies have examined the timing of introduction of specific foods, namely milk and egg. In a prospective cohort, Katz et al found an overall incidence of IgE-mediated milk allergy of 0.5%. The median age of introduction among milk-tolerant infants was 61.6 days, compared to 116.1 days for milk-allergic infants. 58 Koplin et al reported that, compared to introduction of egg between 4 and 6 months of age, delayed introduction was associated with a higher risk of egg allergy, with an odds ratio (OR) of 1.6 for those introduced to egg at 10-12 months and 3.4 for those introduced when older than 12 months. 59 While the optimal timing for the introduction of foods to induce tolerance remains under investigation, the above studies suggest that delaying food introduction beyond 4-6 months of age may increase the risk for food allergy rather than prevent its development.
Fewer studies have examined factors in childhood that are associated with the development of allergic disease. In a cross-sectional study examining children in an allergy clinic, DeMuth et al found that history of taking antacid medication in children according to parental report was associated with an increased prevalence of food allergy. 60 This may be explained by the effects of antacids on gastric pH and subsequent influence on the digestion of proteins.
Complementary and alternative medicines
An estimated 8.4% of Japanese children use complementary and alternative medicines in the management of their food allergies. Among these, herbal teas are the most common (22%), followed by Chinese herbal medicine (18.5%) and lactic acid bacteria (16%). 61 Of these therapies, most research has focused on a type of Chinese herbal medicine, food allergy herbal formula 2 (FAHF-2). FAHF-2 is a nine-herb formula manufactured in China using a standardized process and monitored for contaminants using high-performance liquid chromatography. 62 Two studies have demonstrated the safety and tolerability of FAHF-2 and offered some evidence of an immunologic modulatory effect. Neither of these studies examined the clinical effect of this formulation. 63, 64 Allergen avoidance Several steps are required for the allergic patient to successfully avoid a particular allergen. They must be appropriately diagnosed, clearly understand what foods to avoid, and be able to identify the allergen on a label. For children, there is an added layer of complexity as their caregivers must be proficient in these skills as well.
There is anxiety associated with the diagnosis of food allergy. A study of seafood-allergic children found that 25% of their parents could not recall dietary advice provided by a physician. Nonetheless, 89% of them implemented a safe diet, although it was often more restrictive than needed. Approximately one in five patients had recurrent reactions following diagnosis. Prescription of an EAI was associated with improved adherence to the diet. 65 In studies of milkallergic children, 85% adhered to a milk-free diet, although this cohort received special infant formula reimbursement, which may bias the sample. Moreover, it is unclear whether these children were avoiding milk because of IgE-mediated submit your manuscript | www.dovepress.com
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O'Keefe et al reactions. 66 Milk is prevalent in many foods and may be a "hidden" allergen. Accordingly, accidental exposures to milk are common and observed in up to 40% of children with milk allergy, although these reactions are usually mild (53%). 67 There are several options available for milk-allergic patients. One study examined camel milk as an alternative and found it was well tolerated. 68 Berni Canani et al examined a new amino acid formula and found that this was a safe alternative for children with milk allergy. 69 Labeling practices to alert consumers to food allergens are varied among manufacturers, with many products bearing a "may contain" precautionary label. In an Australian study, 65% of products had precautionary labels for an allergen that was not listed in the ingredients. 70 There is a high degree of consumer confusion when it comes to food labeling, with less than 5% of the general population able to correctly identify more than 50% of the terms associated with a given allergen. 71 Among food labels, "not suitable" was found to be the most effective in deterring purchase of a product among food-allergic individuals and members of their households. 72 Current food-labeling practices benefit neither the consumer nor the manufacturer. The use of a standardized process would be beneficial to both these groups. 73 Young children with food allergies require assistance from adults to efficiently avoid allergens. Food is consumed at school, and the teacher plays an important role in the safety of food-allergic children. A survey of Mississippi, USA schools found that 97% had at least one food-allergic child, but only 30% had action plans for these students. Schools were more likely to have action plans when the school nurse had received appropriate information from a physician. 74 Similar findings were reported in a Korean study, where 71% of schools relied on parental report of food allergy and 47% had experienced student visits to a school health room due to food allergy. More than 80% relied on self-care without school-wide measures for food allergies. 75 Further, there are many misconceptions among teachers regarding food allergy and anaphylaxis. In a survey of primary school teachers, pollen was thought to be the most common agent to cause anaphylaxis. Among foods, egg and strawberry were the leading suspects. Only 10% of teachers surveyed were aware of EAI and only 4% knew how to administer it. 76 Training programs on the recognition and management of anaphylaxis should be implemented for teachers and other caregivers. Anaphylaxis action plans can be written by physicians and provided for distribution in daycares and schools.
eAis
Most individuals with IgE-mediated food allergy are advised to carry an EAI in case of accidental exposure. There are many barriers to the successful use of an EAI, including the ability to recognize the symptoms of anaphylaxis, the availability of an EAI, and understanding of how to use the EAI. There are additional psychological factors at play, as many patients and parents with an EAI do not use it during anaphylaxis, mostly for reasons relating to fear. 8 In almost 50% of cases, an EAI is not carried by individuals with food allergy. [77] [78] [79] Barriers to EAI availability include having the device on one's person and having a device that has not expired. Similarly, many patients are not skilled in the use of their EAIs, with 62%-87% demonstrating errors in use. Repeated instruction can improve both self-carry practices and the individual's ability to use an EAI. 77, 79 While prescription of an EAI is often necessary, it does impact quality of life. Pinczower et al found that prescription of an EAI negatively impacted health-related quality of life, along with being allergic to multiple foods, a history of severe reaction, and patient age 7-12 years. 80 
immunotherapy
Immunotherapy is an attractive option for the treatment of food allergies, as its goal is to induce tolerance in the subject. Patients are considered to be tolerant when they can safely consume the food without following a daily oral food regimen to maintain clinical non-reactivity. In most oral immunotherapy (OIT) protocols, small amounts of allergen are administered orally to patients in gradually increasing amounts, with the immediate goal to induce desensitization. With desensitization, the treated patient manifests a decreased response to the ingested food allergens but must continue to take daily food doses.
Peanut is one of the most common food allergens, and is of great concern given that accidental ingestion of even a very small amount can cause life-threatening reactions and that peanut allergy is typically life-long.
Allergen-specific OIT for peanut allergy aims to induce desensitization and, potentially, tolerance to peanut. However, at present, there is still considerable uncertainty about the effectiveness and safety of this approach.
Three randomized controlled studies have been published on this subject. Anagnostou et al conducted a randomized controlled trial (RCT) of peanut OIT using peanut flour in two phases. In the first phase, 62% of 39 participants achieved desensitization after 6 months of OIT, defined as a negative peanut challenge to 1,400 mg of peanut protein. In the control group, who avoided peanuts, there were no participants who achieved desensitization. In the second phase, the control group underwent OIT, with 54% achieving desensitization. Side effects were generally mild,
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Optimal diagnosis and management of food allergies with gastrointestinal complaints being the most common. 81 Varshney et al randomized 28 subjects to receive either OIT with peanut flour or placebo. Initial escalation, build-up, and maintenance phases were followed by an OFC at 1 year with titrated skin prick tests and laboratory studies performed at regular intervals. Three subjects in the treatment group withdrew early because of side effects, but all remaining peanut subjects (n=16) ingested the maximum cumulative dose of 5,000 mg (approximately 20 peanuts) after 1 year versus 280 mg in the placebo group (P,0.001). Several immunological changes accompanied successful completion of the OIT protocol: decreased SPT wheal size and Th2 cytokine production and increased IgG 4 and Treg cells. There was no significant change in peanut-sIgE levels. Adverse effects were frequent, but the majority were mild. 82 Fleischer et al also published an RCT in 2013 to investigate safety, efficacy, and immunologic effects of peanut SLIT in 40 peanut-allergic children. After 44 weeks of SLIT, 14 of 20 (70%) subjects receiving peanut SLIT were responders, compared with three of 20 (15%) subjects receiving placebo (P,0.001). In peanut SLIT responders, the median successful consumed dose increased from 3.5 to 496 mg. After 68 weeks of SLIT, the median successful consumed dose significantly increased to 996 mg. With regard to side effects, of 10,855 peanut doses administered through to week 44, 63.1% of patients were symptom free; excluding oropharyngeal symptoms, 95.2% were symptom free. 83 In 2013, Chin et al published a letter to an editor to retrospectively compare two RCTs of OIT versus SLIT in peanut-allergic children. They found that, after 2 years, OIT was associated with greater immunological changes in sIgE and IgG 4 levels basophil activation, and IgE/IgG 4 ratio. Clinically, they found that dose thresholds were lower and more variable during DBPCFC at 12 months in SLIT versus OIT. 84 Additionally, other small, uncontrolled trials show suggestive evidence that OIT can increase the threshold dose for peanut exposure. [85] [86] [87] There are few studies published on long-term outcomes of peanut OIT. Vickery et al prospectively followed a group of patients who underwent 5 years of treatment with peanut OIT. They found that 12 of 24 patients (50%) had sustained unresponsiveness to peanut 1 month after discontinuing therapy. 88 Adverse effects are common, but OIT appears to be relatively safe if administered in a carefully monitored setting. Nevertheless, there remains concern about safety, with several studies having evaluated this. In a retrospective chart review examining data from five clinics performing peanut OIT, Wasserman et al reported that, among 352 patients receiving 240,351 doses of OIT, there were 95 reactions requiring treatment with epinephrine. 89 Two studies have evaluated home dosing, and reported reactions in 2.6%-3.7% of total daily home doses. 90, 91 In one of these studies, two reactions required epinephrine. 91 In the RCT published by Varshney et al, 82 47% of the patients had mild-to-moderate side effects requiring antihistamines during the initial rush phase, with two patients requiring epinephrine. During the build-up phase and home doses, none of the peanut OIT patients required epinephrine.
Hofmann et al found that patients were more likely to develop significant allergic symptoms during the initial escalation day than during other phases. Upper respiratory tract (79%) and abdominal (68%) symptoms were the most frequent symptoms at that phase. The risk of having any symptom after the build-up phase was 46% and the risk of reaction with home dosing was 3.5%. 91 Yu et al presented data of an ongoing Phase I single-center trial of peanut OIT. Symptoms were mostly mild (84%) and self-resolved or were resolved with antihistamines; 13% were moderate and 3% were severe. Of the severe symptoms, three gastrointestinal reactions required epinephrine. Abdominal pain was the most common reaction, followed by oropharyngeal and lip pruritus. Respiratory symptoms were rare. 92 OIT has been explored for other common food allergens including milk and egg. In 2012, Yeung et al published a Cochrane Review on milk OIT (MOIT). At that time, the authors identified five RCTs in order to compare OIT to placebo or avoidance. A total of 196 (106 treatment and 90 control) children were enrolled in these studies. The primary outcome of these studies was successful desensitization, but long-term tolerance was not assessed. According to this Cochrane Review, MOIT was proved to be an effective method of inducing (partially) desensitization. Yeung et al reported that 62% of the children in the MOIT group could tolerate 200 mL of milk versus 8% in the control group. Twenty-five percent of the children tolerated 10-184 mL of milk versus 0% in the control group. In general, the authors described low-quality studies with small numbers and different treatment protocols. 93 Since that publication, there has been only one RCT performed, which was by Pajno et al in 2013 and which compared two different maintenance regimens (daily milk versus milk twice a week) over 1 year following successful cow's milk desensitization. No difference was found in clinical efficacy or adverse effects between the two groups. The levels of sIgG 4 , sIgE and SPT wheal size were comparable between the intervention and control groups. 94 In 2011, Nadeau et al published a pilot study in which they performed rush desensitization to milk using omalizumab. This protocol was successful in 9/10 of the patients. Although all of the patients experienced adverse reactions, most of these were mild and only one case required epinephrine. 95 A major pitfall for OIT in general is the frequency of adverse events. Although most are mild and self-limited, there is a risk of severe reactions necessitating treatment with epinephrine. Two studies examined predictors of achieving tolerance and adverse effects. García-Ara et al evaluated the efficacy and safety of an OIT protocol according to the level of sIgE. They found that the lower the sIgE level at baseline, the earlier tolerance was achieved, and that adverse effects were more frequent when sIgE levels were higher. 96 Vázquez-Ortiz et al identified three variables associated with reaction persistence throughout the OIT: cow milk-sIgE levels of at least 50 kUA/L, SPT wheal size of 9 mm and Sampson severity grades 2, 3 and 4 at baseline food challenge. 97 Currently, there is no evidence that MOIT can induce long-term tolerance. In a letter to the editor, Keet et al 98 published a follow-up of two studies of MOIT (cow's milk) after 5 years to evaluate cow's milk consumption, symptoms, and potential predictors of long-term outcomes. The first study, undertaken by Skripak et al, was a double-blind, placebo-controlled trial with 20 children. 99 The second, performed by Keet et al, was an open-label randomized trial of OIT versus SLIT with 30 children. 100 Sixteen subjects were eligible from each study and they were followed up after a median of 4.5 years.
Thirty one percent of patients could tolerate full servings of cow's milk with minimal or no symptoms. There are several limitations of this report as there was no follow-up serology or SPT, no control group, and no data for quality of life before and after treatment. 98 Two studies have evaluated dietary management strategies other than OIT in milk-allergic children. The first study, published in 2010 by Reche et al, compared the clinical tolerance of a hydrolyzed rice protein formula with an extensively hydrolyzed cow's milk formula (EHCF) in infants with IgE-mediated cow's milk allergy. The authors found no significant differences regarding tolerance achievement, adverse reactions, sIgE level, growth, or clinical tolerance. 101 In a 2013 trial comparing five feeding regimens in milkallergic children (EHCF, EHCF + Lactobacillus rhamnosus GG, hydrolyzed rice formula, soy formula, and amino acid formula), milk-allergic children who received EHCF alone or in combination with L. rhamnosus GG achieved tolerance at 12 months. Significantly more children achieved tolerance after 12 months than their peers who received hydrolyzed rice formula, soy formula, or amino acid-based formula. 69 Both studies were relatively small and larger sample sizes may be needed.
As many egg-allergic patients tolerate baked egg, Leonard et al examined the role of baked egg in acquisition of tolerance. They reported that 89% of egg-allergic patients tolerated baked egg and, over time, 53% became regular egg tolerant, compared to 26% of the control group. Those who tolerated baked egg had lower egg white-sIgE levels. Additionally, inclusion of baked egg in the diet appears to hasten the acquisition of tolerance to regular egg. 102 To date, two RCTs of egg OIT have been published. In 2012, Burks et al reported successful desensitization in 55% of their treatment group (n=40) and none of the placebo group (n=15). After 22 months, this increased to 75% of the OIT group. After discontinuation of OIT and avoidance of all egg products for 6-8 weeks, only 28% of the OIT group tolerated egg in an OFC. This study demonstrates successful desensitization, but long-term tolerance was achieved in less than one-third of participants. 103 Meglio et al published similar data for a group of ten egg-allergic children, demonstrating that 80% were desensitized over a 6-month period, but they did not examine acquisition of tolerance. 104 Tortajada-Girbés et al published a prospective cohort trial of OIT involving 19 egg-allergic children. Most participants (89.5%) reached the target dose of egg and were able to tolerate egg in meals on a weekly basis. There were no severe reactions during this trial, although two participants withdrew as they experienced anaphylaxis with the initial dose of OIT. 105 Two small studies have examined a rush protocol for the administration of egg OIT, demonstrating successful desensitization over 5-12 days. Many participants had reactions during OIT, but these were generally mild or moderate in nature. 106, 107 Ojeda et al examined a home-based egg OIT protocol wherein participants were pretreated with antihistamines. They found that 80.6% of subjects in the intention-to-treat group achieved complete desensitization, tolerating the target dose of one egg, while 3.2% reached incomplete tolerance and 16.2% achieved no tolerance. Children who were tolerant to baked egg at baseline were more likely to achieve tolerance to raw egg throughout the study. 108 Two studies have examined SLIT for peach. After 6 months of SLIT with a Pru p 3 extract, the treatment group tolerated higher doses of peach and had a smaller SPT wheal size and increased specific IgG 4 . 109 In a separate study, García et al demonstrated that, among peach-allergic individuals, the most commonly recognized antigen is Pru p 3 (83.3%). sIgE to Pru p 3 rose in both the SLIT treatment group and the control group, but remained elevated only 
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Optimal diagnosis and management of food allergies in the treatment group. SPT wheal size decreased in the treatment group.
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Conclusion
While the mainstays of diagnosis and management in food allergy remain relatively unchanged, there are several emerging modalities that offer exciting prospects for the future. Though we rely heavily on SPT, component testing will likely contribute to improved diagnostic accuracy. OFCs are safe when performed appropriately and improve patients' quality of life. While management strategies are currently limited to allergen avoidance and emergency treatment of accidental exposures, immunotherapy trials offer great promise for developing desensitization. Future studies exploring strategies to induce tolerance are required. Improved diagnostic capabilities and management techniques will revolutionize food allergy diagnosis and management for physicians and patients alike in years to come.
